Under normal conditions, antigen-activated T lymphocytes can specifically recognize tumor cells and directly kill them, while the combination of PD-L1 and PD-1 may induce T-cell apoptosis, anergy, exhaustion [51–53], and the expression of interleukin 10 (IL-10), a negative regulator of cellular immune responses [54]. This evidence concerns the gene IL10 and neoplasm.